Analyst stock forecast
Akari Therapeutics Plc Forecast: $28.39 Analyst Target
AKTX has a $28.39 target, none rating and 2 analysts. As of 2026-08-15.
Direct answer
Akari Therapeutics Plc's average price target is $28.39.
The target implies +276.5% from the recorded current price, and the consensus rating is none.
The low target implies +255.2%, the high target implies +297.9%, and the range spans 42.7% of the current price.
Forecast evidence checked August 15, 2026.
Get free Akari Therapeutics Plc email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Current price
- $7.54
- Average price target
- $28.39
- High price target
- $30.00
- Low price target
- $26.78
- Low target gap
- +255.2%
- Target upside
- +276.5%
- High target gap
- +297.9%
- Target range width
- 42.7%
- Consensus rating
- none
- Analysts
- 2
- Evidence date
- August 15, 2026
- Valid through
- August 22, 2026